Copy number gain of <it>MYCN</it> gene is a recurrent genetic aberration and favorable prognostic factor in Chinese pediatric neuroblastoma patients
<p>Abstract</p> <p>Background</p> <p>Amplification of <it>MYCN</it> oncogene is an established marker indicating aggressive tumor progression of neuroblastoma (NBL). But copy number analyses of <it>MYCN</it> gene in ganglioneuroblastoma (GNBL) an...
Saved in:
Main Authors: | Wang Miao (Author), Zhou Chunju (Author), Cai Rongqin (Author), Li Yong (Author), Gong Liping (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MYCN protein stability is a better prognostic indicator in neuroblastoma
by: Yi Yang, et al.
Published: (2022) -
Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma
by: Haiwei Wang, et al.
Published: (2021) -
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
by: Eunjin Lee, et al.
Published: (2020) -
The potential molecularly therapy target to MYCN‐amplificated neuroblastoma
by: Susu Jiang, et al.
Published: (2023) -
Prognostic significance of MYCN related genes in pediatric neuroblastoma: a study based on TARGET and GEO datasets
by: Haiwei Wang, et al.
Published: (2020)